← Back to headlines
Cocrystal Completes Dosing Phase in Norovirus Drug Trial
The pharmaceutical company has finished enrolling patients and administering doses in its clinical study for a novel norovirus treatment.
9 Sept, 11:04 — 9 Sept, 11:04
Sources
Showing 1 of 1 sources
